Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Atomo Diagnostics Ltd. ( (AU:AT1) ) has shared an announcement.
Atomo Diagnostics Ltd. has announced the quotation of 46,929,731 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of May 5, 2025. This move is part of a previously announced transaction, potentially enhancing the company’s market presence and providing opportunities for stakeholders to engage with its growth strategy.
More about Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. operates in the medical diagnostics industry, focusing on the development and manufacturing of innovative rapid diagnostic test devices. The company is known for its user-friendly, integrated testing solutions that cater to both professional and consumer markets.
Average Trading Volume: 458,408
Technical Sentiment Signal: Buy
Current Market Cap: A$12.14M
Find detailed analytics on AT1 stock on TipRanks’ Stock Analysis page.